Literature DB >> 29884768

Novel hyperoxidation resistance motifs in 2-Cys peroxiredoxins.

Jesalyn A Bolduc1, Kimberly J Nelson1, Alexina C Haynes1, Jingyun Lee2, Julie A Reisz3, Aaron H Graff1, Jill E Clodfelter1, Derek Parsonage1, Leslie B Poole1,2,4,5, Cristina M Furdui3,2,4,5, W Todd Lowther6,2,4,5.   

Abstract

2-Cys peroxiredoxins (Prxs) modulate hydrogen peroxide (H2O2)-mediated cell signaling. At high H2O2 levels, eukaryotic Prxs can be inactivated by hyperoxidation and are classified as sensitive Prxs. In contrast, prokaryotic Prxs are categorized as being resistant to hyperoxidation and lack the GGLG and C-terminal YF motifs present in the sensitive Prxs. Additional molecular determinants that account for the subtle differences in the susceptibility to hyperoxidation remain to be identified. A comparison of a new, 2.15-Å-resolution crystal structure of Prx2 in the oxidized, disulfide-bonded state with the hyperoxidized structure of Prx2 and Prx1 in complex with sulfiredoxin revealed three structural regions that rearrange during catalysis. With these regions in hand, focused sequence analyses were performed comparing sensitive and resistant Prx groups. From this combinatorial approach, we discovered two novel hyperoxidation resistance motifs, motifs A and B, which were validated using mutagenesis of sensitive human Prxs and resistant Salmonella enterica serovar Typhimurium AhpC. Introduction and removal of these motifs, respectively, resulted in drastic changes in the sensitivity to hyperoxidation with Prx1 becoming 100-fold more resistant to hyperoxidation and AhpC becoming 800-fold more sensitive to hyperoxidation. The increased sensitivity of the latter AhpC variant was also confirmed in vivo These results support the function of motifs A and B as primary drivers for tuning the sensitivity of Prxs to different levels of H2O2, thus enabling the initiation of variable signaling or antioxidant responses in cells.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cys sulfinic acid; X-ray crystallography; cell signaling; enzyme kinetics; oxidation-reduction (redox); peroxiredoxin; protein oxidation; redox biology; structural biology

Mesh:

Substances:

Year:  2018        PMID: 29884768      PMCID: PMC6066324          DOI: 10.1074/jbc.RA117.001690

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Jong-Gil Park; Ji-Young Yoo; Se-Jin Jeong; Jae-Hoon Choi; Mi-Ran Lee; Mi-Ni Lee; Jeong Hwa Lee; Hyoung Chin Kim; Hanjoong Jo; Dae-Yeul Yu; Sang Won Kang; Sue Goo Rhee; Mun-Han Lee; Goo Taeg Oh
Journal:  Circ Res       Date:  2011-08-11       Impact factor: 17.367

2.  Molecular basis for the resistance of human mitochondrial 2-Cys peroxiredoxin 3 to hyperoxidation.

Authors:  Alexina C Haynes; Jiang Qian; Julie A Reisz; Cristina M Furdui; W Todd Lowther
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

Review 3.  Regulation of protein tyrosine phosphatases by reversible oxidation.

Authors:  Arne Ostman; Jeroen Frijhoff; Asa Sandin; Frank-D Böhmer
Journal:  J Biochem       Date:  2011-08-19       Impact factor: 3.387

4.  Dimers to doughnuts: redox-sensitive oligomerization of 2-cysteine peroxiredoxins.

Authors:  Zachary A Wood; Leslie B Poole; Roy R Hantgan; P Andrew Karplus
Journal:  Biochemistry       Date:  2002-04-30       Impact factor: 3.162

Review 5.  Reduction of cysteine sulfinic acid in eukaryotic, typical 2-Cys peroxiredoxins by sulfiredoxin.

Authors:  W Todd Lowther; Alexina C Haynes
Journal:  Antioxid Redox Signal       Date:  2010-12-17       Impact factor: 8.401

6.  Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-κB-mediated iNOS induction and microglial activation.

Authors:  Sun-Uk Kim; Young-Ho Park; Ju-Sik Min; Hu-Nan Sun; Ying-Hao Han; Jin-Mei Hua; Tae-Hoon Lee; Sang-Rae Lee; Kyu-Tae Chang; Sang Won Kang; Jin-Man Kim; Dae-Yeul Yu; Sang-Ho Lee; Dong-Seok Lee
Journal:  J Neuroimmunol       Date:  2013-04-17       Impact factor: 3.478

7.  Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace.

Authors:  Thomas J Jönsson; Lynnette C Johnson; W Todd Lowther
Journal:  Nature       Date:  2008-01-03       Impact factor: 49.962

8.  ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin.

Authors:  Benoît Biteau; Jean Labarre; Michel B Toledano
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

9.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.

Authors:  Fabian Sievers; Andreas Wilm; David Dineen; Toby J Gibson; Kevin Karplus; Weizhong Li; Rodrigo Lopez; Hamish McWilliam; Michael Remmert; Johannes Söding; Julie D Thompson; Desmond G Higgins
Journal:  Mol Syst Biol       Date:  2011-10-11       Impact factor: 11.429

Review 10.  Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases.

Authors:  Mi Hee Park; MiRan Jo; Yu Ri Kim; Chong-Kil Lee; Jin Tae Hong
Journal:  Pharmacol Ther       Date:  2016-04-26       Impact factor: 12.310

View more
  18 in total

1.  The bicarbonate/carbon dioxide pair increases hydrogen peroxide-mediated hyperoxidation of human peroxiredoxin 1.

Authors:  Daniela R Truzzi; Fernando R Coelho; Veronica Paviani; Simone V Alves; Luis E S Netto; Ohara Augusto
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

2.  Unraveling the effects of peroxiredoxin 2 nitration; role of C-terminal tyrosine 193.

Authors:  Lía M Randall; Joaquín Dalla Rizza; Derek Parsonage; Javier Santos; Ryan A Mehl; W Todd Lowther; Leslie B Poole; Ana Denicola
Journal:  Free Radic Biol Med       Date:  2019-07-16       Impact factor: 7.376

3.  Differential peroxiredoxin hyperoxidation regulates MAP kinase signaling in human articular chondrocytes.

Authors:  John A Collins; Scott T Wood; Jesalyn A Bolduc; N P Dewi Nurmalasari; Susan Chubinskaya; Leslie B Poole; Cristina M Furdui; Kimberly J Nelson; Richard F Loeser
Journal:  Free Radic Biol Med       Date:  2019-01-09       Impact factor: 7.376

4.  Characterization of the peroxiredoxin 1 subfamily from Tetrahymena thermophila.

Authors:  Sarmad Al-Asadi; Arif Malik; Rigers Bakiu; Gianfranco Santovito; Ian Menz; Kathryn Schuller
Journal:  Cell Mol Life Sci       Date:  2019-05-25       Impact factor: 9.261

5.  Native state fluctuations in a peroxiredoxin active site match motions needed for catalysis.

Authors:  Aidan B Estelle; Patrick N Reardon; Seth H Pinckney; Leslie B Poole; Elisar Barbar; P Andrew Karplus
Journal:  Structure       Date:  2021-10-21       Impact factor: 5.006

6.  Differential parameters between cytosolic 2-Cys peroxiredoxins, PRDX1 and PRDX2.

Authors:  Joaquín Dalla Rizza; Lía M Randall; Javier Santos; Gerardo Ferrer-Sueta; Ana Denicola
Journal:  Protein Sci       Date:  2018-11-12       Impact factor: 6.725

7.  A Proteomic Approach to Uncover Neuroprotective Mechanisms of Oleocanthal against Oxidative Stress.

Authors:  Laura Giusti; Cristina Angeloni; Maria Cristina Barbalace; Serena Lacerenza; Federica Ciregia; Maurizio Ronci; Andrea Urbani; Clementina Manera; Maria Digiacomo; Marco Macchia; Maria Rosa Mazzoni; Antonio Lucacchini; Silvana Hrelia
Journal:  Int J Mol Sci       Date:  2018-08-08       Impact factor: 5.923

8.  The Peroxidatic Thiol of Peroxiredoxin 1 is Nitrosated by Nitrosoglutathione but Coordinates to the Dinitrosyl Iron Complex of Glutathione.

Authors:  Daniela R Truzzi; Simone V Alves; Luis E S Netto; Ohara Augusto
Journal:  Antioxidants (Basel)       Date:  2020-03-25

9.  Hyperoxidation of mitochondrial peroxiredoxin limits H2 O2 -induced cell death in yeast.

Authors:  Gaetano Calabrese; Esra Peker; Prince Saforo Amponsah; Michaela Nicole Hoehne; Trine Riemer; Marie Mai; Gerd Patrick Bienert; Marcel Deponte; Bruce Morgan; Jan Riemer
Journal:  EMBO J       Date:  2019-08-07       Impact factor: 11.598

Review 10.  Peroxiredoxins in Cancer and Response to Radiation Therapies.

Authors:  Tom E Forshaw; Reetta Holmila; Kimberly J Nelson; Joshua E Lewis; Melissa L Kemp; Allen W Tsang; Leslie B Poole; W Todd Lowther; Cristina M Furdui
Journal:  Antioxidants (Basel)       Date:  2019-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.